The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback